Latest News about BMY
Recent news which mentions BMY
Mirati's Sitravatinib Flunks Phase 3 Combo Therapy Study In Type Of Lung Cancer Setting
May 25, 2023
From Benzinga
Quant Ratings Updated on 119 Stocks
May 23, 2023
From InvestorPlace
From Benzinga
From Benzinga
Pfizer CEO Fires Back On US Drug Pricing Reforms: 'Negotiation with a Gun to Your Head'
May 12, 2023
From Benzinga
From Motley Fool
Tickers
BMY
From Motley Fool
$100,000 Salaries No Longer Enough — Majority Living Paycheck To Paycheck With No Savings
May 09, 2023
From Benzinga
From Motley Fool
Tickers
BMY
From Motley Fool
Insiders Selling Zoom Video Communications, Bristol-Myers Squibb And This Footwear Manufacturer
May 05, 2023
From Benzinga
7 Best Dividend Stocks to Buy Now in May 2023
May 03, 2023
From Motley Fool
From Motley Fool
From Benzinga
Bristol-Myers Squibb's Breyanzi Aces Two Lymphoma Studies On Overall Response Rate Endpoint, Plus New Collaboration
May 01, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 27, 2023
From Benzinga
Bristol Myers Squibb Posts Lower Q1 Sales As Revlimid Generic Erosion Bites, Chairman & CEO Giovanni Caforio To Step Down
April 27, 2023
Tickers
BMY
From Benzinga
A New Depression Drug Being Developed By Tonix May Side-Step Treatment-Limiting Effects Of Nearly All Current Antidepressants In The US
April 27, 2023
From Benzinga
US Stocks Eye Higher Open As Meta Q1 Uplifts Tech Sector: Analyst Says 'No Earnings Recession In Cards Yet'
April 27, 2023
From Benzinga
LianBio Touts Positive Data From Bristol Myers-Partnered Heart Drug In Chinese Patients
April 26, 2023
From Benzinga
From Benzinga
Bristol-Myers Squibb Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 25, 2023
Tickers
BMY
From Benzinga
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
